Procter & Gamble CO 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
The Procter & Gamble Company announced its fiscal year 2026 results, showcasing a 3% increase in net sales to $87.0 billion and a 2% rise in diluted EPS to $6.62.
NYSE
Procter & Gamble reported increased net earnings and diluted EPS for fiscal year 2025, driven by reduced selling, general, and administrative costs and the absence of a prior-year impairment charge, despite ongoing restructuring efforts.
NYSE
Procter & Gamble's 2024 annual report highlights a 2% increase in net sales, driven by pricing and organic growth, alongside a 12% increase in core earnings per share, while also addressing macroeconomic headwinds and strategic restructuring.